Universitaetsklinikum Regensburg AöR

At Universitaetsklinikum Regensburg AöR, clinical trials in Eye Diseases focus on urgent vision-threatening conditions such as acute central retinal artery occlusion. The research aims to improve recovery of sight and to test more effective approaches for restoring visual function after sudden retinal injury.

• Recovery of vision in acute retinal artery occlusion
• Functional improvement measured through visual acuity outcomes
• Testing new strategies to protect or restore eyesight

These studies reflect a strong interest in faster diagnosis and better treatment options for patients facing sudden loss of vision.

The site conducts a broad range of trials in Neoplasms, including melanoma, solid tumors, non-small cell lung cancer, gastroesophageal adenocarcinoma, and head and neck cancers. Many of these studies evaluate immunotherapy combinations and other targeted treatments to improve tumor control, delay recurrence, and extend survival.

• Melanoma and metastatic melanoma
• Locally advanced or metastatic non-small cell lung cancer
• Head and neck squamous cell carcinoma
• Advanced gastroesophageal adenocarcinoma

The oncology portfolio includes both treatment innovation and post-surgery recurrence prevention, showing a clear focus on more personalized cancer care.

Research in immune system diseases and neoplasms includes trials for acute myeloid leukemia, myelodysplastic syndromes, classical Hodgkin lymphoma, and aggressive B-cell lymphoma in children and adolescents. These studies are designed to refine treatment effectiveness, preserve event-free survival, and support immune recovery while reducing treatment burden where possible.

• Acute myeloid leukemia and related myelodysplastic syndromes
• Classical Hodgkin lymphoma
• Pediatric mature aggressive B-cell lymphoma and leukemia
• Evaluating optimized chemotherapy and immunotherapy combinations

This area highlights the clinic’s role in advancing both adult and pediatric blood cancer research.

Trials in Cardiovascular Diseases address high-risk conditions such as acute myocardial infarction. The main purpose is to improve early treatment and reduce the risk of recurrent cardiac events through better use of anti-thrombotic and emergency therapies.

• Acute myocardial infarction
• Preventing repeat cardiac events
• Evaluating rapid self-administered treatment approaches

These studies emphasize timely intervention in life-threatening cardiovascular emergencies.

Research involving immune system processes includes studies in kidney transplant recipients focused on prophylaxis of transplant rejection. The goal is to compare treatment options that may improve drug exposure and support long-term graft protection after transplantation.

• Kidney transplant recipients
• Prevention of transplant rejection
• Comparing oral immunosuppressive treatment performance

These trials contribute to safer and more reliable post-transplant care.

The site also studies skin and connective tissue diseases, especially hidradenitis suppurativa. This work evaluates whether newer anti-inflammatory treatments can better control symptoms in people with moderate to severe disease who have not responded adequately to prior therapy.

• Hidradenitis suppurativa
• Chronic inflammatory skin disease management
• Assessing treatment effectiveness and tolerability

Overall, the research aims to improve symptom control and quality of life for patients with difficult-to-treat inflammatory skin conditions.